Supporting our NEIL3 interaction finding, fonofos has previously been associated with prostate cancer in the AHS among participants with a family history of prostate cancer (Alavanja et al. 2003; Mahajan et al. 2006), which suggested a role of genetic susceptibility to carcinogenic effects of this chemical. The gene discussed is NEIL3; the disease is prostate carcinoma.